Asia Pacific Infectious Disease Diagnosis & Treatment Market is Growing At A CAGR Of 7.8% Forecast to 2023
Asia Pacific Infectious Disease Diagnosis & Treatment Market Research Report, By Applications (AIDS, Tuberculosis (TB), Hepatitis, HPV, And Others), By Treatment Forecast Till 2023
Pune, India – July 6, 2017 /MarketersMedia/ —
Infectious diseases includes diseases like tuberculosis, hepatitis and many other diseases caused by viruses, fungi or bacteria. Asia Pacific region has tropical climate and more humidity which is more suitable for the growth of the different microorganisms which can cause different diseases. Increasing prevalence of Infectious diseases such as tuberculosis and AIDS in Asia Pacific region is the major driving factor for the growth of the market. Increasing burden of different infectious diseases has increase the demand for the different diagnostic test and treatment for the different infectious diseases. Asia Pacific infectious disease diagnosis & treatment market is expected to grow at a CAGR of 7.8 % during forecasted period.
On regional basis, China commands the largest market for Asia Pacific infectious disease diagnosis & treatment market. Presence of huge population and increasing peoples suffering from TB are the major reason for the development of this market in China. China contribute 10 % of total TB population in the world. India has the second largest market for infectious disease diagnosis & treatment. Presence of highest TB patient in the world is the major driving factor for the market. Continuous development in the healthcare sector and increasing healthcare expenditure is also increased the infectious disease diagnosis & treatment market in India.
Get a sample report at https://www.marketresearchfuture.com/sample_request/1322 .
Asia Pacific infectious disease diagnosis & treatment market is segmented on the basis of application into AIDS, Tuberculosis (TB), Hepatitis, HPV, and others. On the basis treatment it is segmented into Antibiotics, antivirals, antifungals, anti-parasitic, alternative medicine and others. On the basis of diagnostic techniques they are immunoassays, PCR, cell cultures and other and by end user the market is segmented as hospitals, clinics, reference labs and others
Key players for Asia Pacific infectious disease diagnosis & treatment market
• Abbott Laboratories (US)
• Becton Dickinson & Co. (US)
• Alere, Inc. (US)
• Bio-Rad Laboratories (US)
• Cipla (India)
• Danaher Corporation (US)
• Glaxosmithkline (UK)
• IPCA Laboratories (India)
• Pfizer (US)
• Roche Diagnostics (Switzerland)
• Johnson And Johnson (US)
• Novartis International (Switzerland)
• Siemens Healthcare (Germany)
• Thermo Fisher Scientific, Inc. (US)
• Vertex Pharmaceuticals (US)
Browse Complete Report at https://www.marketresearchfuture.com/reports/apac-infectious-disease-diagnosis-treatment-market-1322 .
Due to increasing prevalence infectious diseases like tuberculosis and AIDS in Asia Pacific region has attracted many companies for the development of the market in Asia Pacific region. Companies are concentrating on the development of new and better diagnostic test and treatment for the different diseases. Companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market.
Abbott Laboratories one of the leading pharmaceutical company headquartered in US. Varicella Zoster Virus (VZV) PCR Kit, ARCHITECT HIV Ag/Ab Combo, Anti-HAV IgM, HIV Ag/Ab Combo and RealTime High-Risk HPV are some of the devices and drugs used in the treatment and diagnosis of infectious diseases. The Parvo B19 PCR Kit is a diagnostic system for the detection of Parvovirus B19 DNA using PCR. Abbott Laboratories diagnostics, molecular diagnostics sales totaled $117 million in Q4 2015 worldwide.
Becton Dickinson & Co is a manufacture and sells medical devices, instrument systems, and reagents headquartered in US. Becton Dickinson & Co has recently acquired Difco, Inc. BD BACTEC and BD BBL are famous Mycobacteria testing systems. Company also manufactures syringes and culture media used for the diagnosis of the diseases. Becton Dickinson & Co diagnostic market is increased by 6 % in 2016.
Bio-Rad Laboratories, Inc. develop and produce the chemicals used in biochemical, pharmaceutical, and other life science research applications. BioPlex is the widely used kit for the treatment of infectious diseases. Globally clinical diagnostics segment net sales for the fourth quarter were $360.8 million, an increase of 3.5 percent compared to the same period in 2015.
Get a Discount at https://www.marketresearchfuture.com/check-discount/1322 .
The report for Asia Pacific infectious disease diagnosis & treatment market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Contact Info:
Name: Akash Anand
Email: Akash.Anand@Marketresearchfuture.Com
Organization: Market Research Future
Address: Market Research Future Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312
For more information, please visit https://www.marketresearchfuture.com/reports/apac-infectious-disease-diagnosis-treatment-market-1322
Source: MarketersMedia
Release ID: 215225
Copyright © 1999-2013 SproutNews.com
